1
|
Francolini G, Allegra A, Caini S, Detti B, Di Cataldo V, Alitto A, Parisi S, D’Angelillo R, Bruni A, Ingrosso G, Timon G, Burchini L, Frosini G, Valzano M, Ganovelli M, Desideri I, Visani L, Olmetto E, Becherini C, Salvestrini V, Lapini A, Meattini I, Livi L. Early outcomes from a phase II randomized trial testing stereotactic body radiation therapy in patients undergoing I line treatment with abiraterone acetate for oligometastatic castration resistant prostate cancer (ARTO trial-NCT03449719). Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01226-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
2
|
Benziane-Ouaritini N, Zilli T, Ingrosso G, di Staso M, Trippa F, Francolini G, Meyer E, Achard V, Schick U, Cosset J, Martin E, Penna RR, Ferrari V, Giraud N, Pasquier C, Magne N, Anger E, Aristei C, Perrenec T, Gnep K, Pasquier D, Supiot S, Sargos P, Latorzeff I. Salvage Radiotherapy Guided by Functional Imaging for Macroscopic Local Recurrence Following Radical Prostatectomy: A Multicentric Retrospective Study. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
3
|
Francolini G, Detti B, Di Cataldo V, Caini S, Alitto A, S. Parisi, Demofonti C, Bruni A, Ingrosso G, Timon G, Allegra A, Burchini L, Salvestrini V, Frosini G, Cerbai C, Visani L, Becherini C, Desideri I, Meattini I, Livi L. 1369P Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
4
|
Benziane N, Sargos P, Zilli T, Giraud A, Ingrosso G, Di Staso M, Trippa F, Meyer E, Francolini G, Schick U, Cosset J, Martin E, Ferrari V, Achard V, Giraud N, Pasquier C, Magné N, Pasquier D, Supiot S, Latorzeff I, Gnep K, Pommier P, Perennec T, Zaine H. OC-0607 Radiotherapy guided by functional imaging for macroscopic local recurrence following prostatectomy. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02629-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Francolini G, Detti B, Di Cataldo V, Caini S, Alitto A, Parisi S, Demofonti C, Bruni A, Ingrosso G, Timon G, Tagliagambe A, Aquilano M, Ciccone L, Salvestrini V, Frosini G, Cerbai C, Allegra A, Burchini L, Desideri I, Mangoni M, Meattini I, Livi L. OC-0605 Early outcomes of a randomized trial of SBRT and Abiraterore in mCPRC: ARTO trial NCT03449719. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02627-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
6
|
Cuccia F, Mazzola R, Pastorello E, Ingrosso G, Franzese C, Scorsetti M, Figlia V, Giaj-Levra N, Nicosia L, Rigo M, Ricchetti F, Vitale C, Attinà G, Ruggieri R, Alongi F. PD-0086 PSMA-PET guided stereotactic body radiotherapy for bone oligorecurrent prostate cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02756-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
7
|
Francolini G, Detti B, Becherini C, Caini S, Ingrosso G, Di Cataldo V, Stocchi G, Salvestrini V, Lancia A, Scartoni D, Giacomelli I, Sardaro A, Carbonara R, Borghesi S, Aristei C, Livi L. Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature. Crit Rev Oncol Hematol 2021; 165:103432. [PMID: 34352361 DOI: 10.1016/j.critrevonc.2021.103432] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 07/06/2021] [Accepted: 07/28/2021] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Moderately hypofractionated radiotherapy (RT) currently represents the standard RT approach for all prostate cancer (PCa) risk categories. We performed a systematic review and meta-analysis of available literature, focusing on acute and late genitourinary (GU) and gastrointestinal (GI) adverse events (AEs) of moderate hypofractionation for localized PCa. MATERIALS AND METHODS Literature search was performed and two independent reviewers selected the records according to the following Population (P) Intervention (I) Comparator (C) and Outcomes (O) (PICO) question: "In patients affected by localized PCa (P), moderately hypofractionated RT (defined as a treatment schedule providing a single dose per fraction of 3-4.5 Gy) (I) can be considered equivalent to conventionally fractionated RT (C) in terms of G > 2 GI and GU acute and late adverse events (O)?". Bias assessment was performed using Cochrane Cochrane Collaboration's Tool for Assessing Risk of Bias. RESULTS Thirteen records were identified and a meta-analysis was performed. Risk of acute GI and GU > 2 adverse events in the moderately hypofractionated arm was increased by 9.8 % (95 %CI 4.8 %-14.7 %; I2 = 57 %) and 1.5 % (95 % CI -1.5 %-4.4 %; I2 = 0%), respectively. DISCUSSION Overall, majority of trials included in our meta-analysis suggested that moderately hypofractionated RT is equivalent, in terms of GI and GU adverse events, to conventional fractionation. Pooled analysis showed a trend to increased GI toxicity after hypofractionated treatment, but this might be related to dose escalation rather than hypofractionation.
Collapse
Affiliation(s)
- G Francolini
- Radiation Oncology Unit, University of Florence, Florence, Italy
| | - B Detti
- Radiation Oncology Unit, University of Florence, Florence, Italy.
| | - C Becherini
- Radiation Oncology Unit, University of Florence, Florence, Italy
| | - S Caini
- Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
| | - G Ingrosso
- Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Italy
| | | | - G Stocchi
- Radiation Oncology Unit, University of Florence, Florence, Italy
| | - V Salvestrini
- Radiation Oncology Unit, University of Florence, Florence, Italy
| | - A Lancia
- Department of Medical Sciences and Infectious Disease, Radiation Oncology Unit, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy
| | - D Scartoni
- Proton Treatment Center, Azienda Provinciale Per i Servizi Sanitari, Trento, Italy
| | - I Giacomelli
- Proton Treatment Center, Azienda Provinciale Per i Servizi Sanitari, Trento, Italy
| | - A Sardaro
- Section of Radiology and Radiation Oncology, Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy
| | - R Carbonara
- Radiation Oncology Department, General Regional Hospital F. Miulli, Acquaviva delle Fonti, BA, Italy
| | - S Borghesi
- Radiotherapy Department, Azienda USL Toscana Sud Est, San Donato Hospital, Arezzo, Italy
| | - C Aristei
- Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Italy
| | - L Livi
- Radiation Oncology Unit, University of Florence, Florence, Italy
| |
Collapse
|
8
|
Marco L, Trignani M, Ingrosso G, Di Guglielmo F, Centofanti G, Fasciolo D, Bini V, Genovesi D, Aristei C. PO-1071 Hypofractionated stereotactic radiotherapy of brain metastases: a retrospective analysis. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07522-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Bruni A, Mazzeo E, Triggiani L, Frassinelli L, Guarneri A, Bartoncini S, Antognoni P, Gottardo S, Greco D, Borghesi S, Nanni S, Ingrosso G, D’Angelillo R, Detti B, Francolini G, Magli A, Guerini A, Arcangeli S, Spiazzi L, Ricardi U, Lohr F, Magrini S. PO-1347 Prostate cancer RT pattern of practice in Italy between 2004-2011: an analysis by the AIRO database. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07798-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Francolini G, Jereczek-Fossa B, Di Cataldo V, Simontacchi G, Marvaso G, Zerella M, Gentile P, Bianciardi F, Allegretta S, Detti B, Masi L, Ciccone L, Bruni A, Ingrosso G, Mazzeo E, Trippa F, Lohr F, Livi L. PH-0118: Stereotactic or conventional RT for macroscopic prostate bed recurrence: a propensity score analysis. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00145-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
11
|
Saldi S, Panizza B, Massei M, Capolsini I, Fulcheri C, Ingrosso G, Chierchini S, Mariucci C, Perrucci E, Caniglia M, Aristei C. PO-0921: Total Body Irradiation and adoptive immunotherapy in pediatric HLA-haploidentical transplantation. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00938-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
12
|
Francolini G, Detti B, Bottero M, Zilli T, Lancia A, Bruni A, Borghesi S, Mariotti M, Castellucci P, Fanti S, Filippi AR, Teriaca MA, Maragna V, Aristei C, Mazzeo E, Livi L, Ingrosso G. Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series. Clin Transl Oncol 2020; 23:364-371. [PMID: 32602076 DOI: 10.1007/s12094-020-02427-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2020] [Accepted: 06/10/2020] [Indexed: 12/24/2022]
Abstract
AIMS 68Ga-Prostate-specific membrane antigen (PSMA) PET/CT is widely used in patients with biochemical recurrence (BCR) after radical prostatectomy. We collected data about patients staged with PSMA PET/CT after BCR (PSA < 1 ng/ml) in four different institutes. Impact of baseline features (Gleason score, risk classification, PSA at recurrence, PSA doubling time and time to recurrence) was explored to understand predictive factors of (PSMA) PET/CT positivity. Impact of restaging on following treatment approaches was reported. RESULTS 92 patients were included. PSMA PET/CT detection rate was 56.5% and low-volume disease (≤ 3 non-visceral lesions) was detected in 52.2% of patients. After positive scan, 13.5% of patients still lies on observation, ADT alone was administered in 30.8% of cases, Stereotactic body RT (SBRT) alone was delivered to 44.2% of patients and 11.5% of patients underwent concomitant SBRT and ADT. Seven patients underwent conventional salvage prostate bed RT. Chi-squared test showed a higher rate of positive PSMA PET/CT for patients with Gleason score > 7 (p = 0.004) and TTR < 29.5 months (p = 0.003). CONCLUSIONS PSMA PET/CT showed a high detection rate. This influenced clinical management in a significant percentage of patients, allowing treatment tailoring on the basis of imaging.
Collapse
Affiliation(s)
- G Francolini
- Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Largo G. A. Brambilla 3, 50134, Florence, Italy.
| | - B Detti
- Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Largo G. A. Brambilla 3, 50134, Florence, Italy
| | - M Bottero
- Department of Radiation Oncology, Policlinico Tor Vergata, University of Rome, Rome, Italy
| | - T Zilli
- Radiation Oncology Division, Geneva University Hospital, Geneva, Switzerland
| | - A Lancia
- Radiation Oncology Unit, Department of Medical Sciences and Infectious Disease, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - A Bruni
- Radiotherapy Unit, University Hospital of Modena, Modena, Italy
| | - S Borghesi
- UOC Radiation Oncology Arezzo-Valdarno, Azienda USL Toscana Sud Est, Arezzo, Italy
| | - M Mariotti
- Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Largo G. A. Brambilla 3, 50134, Florence, Italy
| | - P Castellucci
- Department of Nuclear Medicine, Policlinico S. Orsola-Malpighi, Bologna, Italy
| | - S Fanti
- Department of Nuclear Medicine, Policlinico S. Orsola-Malpighi, Bologna, Italy
| | - A R Filippi
- Radiation Oncology Unit, Department of Medical Sciences and Infectious Disease, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
| | - M A Teriaca
- Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Largo G. A. Brambilla 3, 50134, Florence, Italy
| | - V Maragna
- Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Largo G. A. Brambilla 3, 50134, Florence, Italy
| | - C Aristei
- Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy
| | - E Mazzeo
- Radiotherapy Unit, University Hospital of Modena, Modena, Italy
| | - L Livi
- Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Largo G. A. Brambilla 3, 50134, Florence, Italy
| | - G Ingrosso
- Radiation Oncology Section, Department of Surgical and Biomedical Science, University of Perugia, Perugia, Italy
| |
Collapse
|
13
|
Bruni A, Ingrosso G, Trippa F, Di Staso M, Rubino L, Aluisio G, Parente S, Frassinelli L, Maranzano E, Santoni R, Mazzeo E, Lohr F. EP-1516 Macroscopic local relapse from prostate cancer: which role for salvage RT? An update analysis. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31936-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Bruni A, Ingrosso G, Trippa F, Di Staso M, Lanfranchi B, Rubino L, Parente S, Frassinelli L, Maranzano E, Santoni R, Sighinolfi MC, Lohr F, Mazzeo E. Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? Clin Transl Oncol 2019; 21:1532-1537. [PMID: 30868389 DOI: 10.1007/s12094-019-02084-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2019] [Accepted: 03/07/2019] [Indexed: 01/12/2023]
Abstract
INTRODUCTION Salvage radiotherapy (SRT) after radical prostatectomy for prostate cancer (PCa) is recommended as soon as PSA rises above 0.20 ng/ml, but many patients (pts) still experience local macroscopic relapse. The aim of this multicentric retrospective analysis was to evaluate the role of SRT in pts with macroscopic relapse. MATERIALS AND METHODS From 2001 to 2016, 105 consecutive pts with macroscopic PCa relapse underwent SRT ± androgen deprivation therapy (ADT). Mean age was 72 years. At time of relapse, 29 pts had a PSA value < 1.0 ng/mL, 50 from 1.1 to 5, and 25 pts > 5. Before SRT, 23 pts had undergone 18F-choline PET and 15 pts pelvic MRI. Ninety-four pts had prostatic bed relapse only, and four nodal involvement. Fifty-one pts were previously submitted to first-line ADT, while 6 pts received ≥ 2 lines. RESULTS At a median follow-up of 52 months, 89 pts were alive, while 16 were dead. Total RT dose to macroscopic lesions was > 70 Gy in 58 pts, 66-70 Gy in 43, and < 66 Gy in 4 pts. In 72 pts, target volume encompassed only the prostatic bed with sequential boost to macroscopic site; 33 pts received prophylactic pelvic RT. Ten-year overall survival was 76.1%, while distant metastasis-free survival was 73.3%. No grade 4-5 toxicities were found. CONCLUSIONS SRT ± ADT for macroscopic relapse showed a favorable oncological outcome supporting its important role in this scenario. Data from this series suggest that SRT may either postpone ADT or improve results over ADT alone in appropriately selected pts.
Collapse
Affiliation(s)
- A Bruni
- Radiotherapy Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy.
| | - G Ingrosso
- Radiotherapy Unit, "Tor Vergata" University General Hospital, Rome, Italy
| | - F Trippa
- Radiotherapy Unit, "Santa Maria" University Hospital, Terni, Italy
| | - M Di Staso
- Radiotherapy Unit, "Nuovo San Salvatore" Hospital, L'Aquila, Italy
| | - B Lanfranchi
- Radiotherapy Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy
| | - L Rubino
- Radiotherapy Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy
| | - S Parente
- Radiotherapy Unit, "Nuovo San Salvatore" Hospital, L'Aquila, Italy
| | - L Frassinelli
- Radiotherapy Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy
| | - E Maranzano
- Radiotherapy Unit, "Santa Maria" University Hospital, Terni, Italy
| | - R Santoni
- Radiotherapy Unit, "Tor Vergata" University General Hospital, Rome, Italy
| | - M C Sighinolfi
- Urology Unit, University Hospital of Modena, Modena, Italy
| | - F Lohr
- Radiotherapy Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy
| | - E Mazzeo
- Radiotherapy Unit, University Hospital of Modena, Via del Pozzo 71, 41100, Modena, Italy
| |
Collapse
|
15
|
Francolini G, Detti B, Ingrosso G, Desideri I, Becherini C, Carta G, Pezzulla D, Caramia G, Dominici L, Maragna V, Teriaca MA, Bottero M, Livi L. Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature. Crit Rev Oncol Hematol 2018; 131:24-29. [PMID: 30293702 DOI: 10.1016/j.critrevonc.2018.08.010] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2018] [Revised: 08/12/2018] [Accepted: 08/22/2018] [Indexed: 12/19/2022] Open
Abstract
BACKGROUND Stereotactic body radiotherapy (SBRT) is characterized by the delivery of high doses of ionizing radiation in few fractions. It is highly effective in achieving local control, and, due to the high biological effective dose administered, it seems to overcome the radioresistance of renal cell carcinoma (RCC). Thus, SBRT could constitute a treatment option for the management of localized RCC in patients who are not surgical candidates. In this paper, we report an overview about data from the current evidence about SBRT in patients affected by localized RCC. MATERIALS AND METHODS A non-systematic review was performed, including data from both retrospective and prospective studies focusing on the use of SBRT for localized RCC and its biological rationale. Furthermore, ongoing trials on this issue are reported. CONCLUSION Currently, SBRT might be considered a treatment alternative in inoperable patients affected by primary RCC. Currently, dose-escalation to 48 Gy in 3-4 fractions are effective and well tolerated. Emerging role of immune therapies in RCC patients warrant further studies to explore interactions between SBRT and immune response.
Collapse
Affiliation(s)
- G Francolini
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - B Detti
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - G Ingrosso
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, Tor Vergata General Hospital, Rome, Italy
| | - I Desideri
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - C Becherini
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - G Carta
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - D Pezzulla
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy.
| | - G Caramia
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - L Dominici
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - V Maragna
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - M A Teriaca
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| | - M Bottero
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, Tor Vergata General Hospital, Rome, Italy
| | - L Livi
- Department of Radiation Oncology, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Italy
| |
Collapse
|
16
|
Lancia A, Ingrosso G, Carosi A, Di Murro L, Giudice E, Cicchetti S, Morelli P, Bruni C, Di Cristino D, Murgia A, Cancelli A, Turturici I, Iadevaia A, Santoni R. EP-1428: Stereotactic body radiotherapy for isolated metastasis from different primitive tumors. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31863-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
17
|
Triggiani L, Magrini S, Bruni A, Alongi F, Magli A, Bonetta A, Livi L, Santoni R, Borghetti P, Maddalo M, Rolando M, Ingrosso G, Pasinetti N, Buglione M. OC-0521: The role of SBRT in oligorecurrent and oligoprogressive prostate cancer: a multi-institutional study. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30961-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Bagala P, Ingrosso G, Falco M, Petrichella S, D'andrea M, Rago M, Lancia A, Bruni C, Ponti E, Santoni R. EP-1713: Dose-volume analysis of genitourinary toxicity in 3-D conformal radiotherapy for prostate cancer. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32964-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
19
|
Tuovinen N, Pasquale FD, Caravasso CF, Giudice E, Miceli R, Ingrosso G, Santoni R, Laprie A, Sabatini U. EP-1883: Functional brain connectivity in glioblastoma patients pre- and post-radiotherapy. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33134-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Miceli R, Ingrosso G, Ponti E, Di Cristino D, Lancia A, Bove P, De Pasquale F, Santoni R. Prostate movements analysis during radiotherapy using volumetric intraprostatic gold coils information. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
21
|
Bagalà P, Ingrosso G, Petrichella S, D'Andrea M, Rago M, Lancia A, Bruni C, Ponti E, Santoni R, Falco M. A dose-volume parameter analysis of the bladder in three-dimensional conformal radiotherapy for localized prostate cancer. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
22
|
Falco MD, D'Andrea M, Fedele D, Barbarino R, Benassi M, Giudice E, Hamoud E, Ingrosso G, Ladogana P, Santarelli F, Tortorelli G, Santoni R. Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer. Br J Radiol 2011; 84:819-25. [PMID: 21849366 DOI: 10.1259/bjr/25741415] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
OBJECTIVES The aim of this study was to define a method to evaluate the total dose delivered to the rectum during the whole treatment course in six patients undergoing irradiation for prostate cancer using an offline definition of organ motion with images from a cone beam CT (CBCT) scanner available on a commercial linear accelerator. METHODS Patient set-up was verified using a volumetric three-dimensional CBCT scanner; 9-14 CBCT scans were obtained for each patient. Images were transferred to a commercial treatment planning system for offline organ motion analysis. The shape of the rectums were used to obtain a mean dose-volume histogram (<DVH>), which was the average of the DVHs of the rectums as they appeared in each verification CBCT. A geometric model of an average rectum (AR) was produced using the rectal contours delineated on the CBCT scans (DVH(AR)). To check whether the first week of treatment was representative of the whole treatment course, we evaluated the DVHs related to only the first five CBCT scans (<DVH5> and DVH(AR5)). Finally, the influence of a dietary protocol on the goodness of our results was considered. RESULTS In all six patients the original rectal DVH for the planning CT scan showed higher values than all DVHs. CONCLUSION Although the application of the model to a larger set of patients is necessary to confirm this trend, reconstruction of a representative volume of the rectum throughout the entire treatment course seems feasible.
Collapse
Affiliation(s)
- M D Falco
- Department of Diagnostic Imaging, Molecular Imaging, Interventional Radiology and Radiotherapy, Tor Vergata University General Hospital, Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Creton G, Benassi M, Di Staso M, Ingrosso G, Giubilei C, Strigari L. The time factor in oncology: consequences on tumour volume and therapeutic planning. J Exp Clin Cancer Res 2006; 25:557-73. [PMID: 17310848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
The rules that govern tumour treatment depend largely on clinical stage (tumour volume, localization and/or metastasis presence). These rules are applied assuming that tumor growth is relatively static without considering the time factor, the number of clonogenic cells in the tumour or the volume reduction following initial cytotoxic therapy. Time and neoplastic growth (with a subsequent change in volume) are generally not considered in 90% of clinical trials, where chemotherapy is administered on the first and eighth day and radiotherapy is carried out five days a week with different schedules. In the clinical situation, however, a tumour has more complex growth times that should be appropriately assessed to improve the treatment results (1). The aim of this paper is to stress the influence of the time factor to optimize the schedule of the cytotoxic therapies, based on different mathematical models developed to describe the tumour growth. To better understand the role of the neoplastic growth at its different clinical stages and the subsequent response to cytotoxic therapies, several elements concerning such growth should be thoroughly analyzed.
Collapse
Affiliation(s)
- G Creton
- Department of Radiotherapy, Cirad Villa Benedetta, Rome, Italy.
| | | | | | | | | | | |
Collapse
|
24
|
Campagnoli MF, Pucci A, Garelli E, Carando A, Defilippi C, Lala R, Ingrosso G, Dianzani I, Forni M, Ramenghi U. Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family. J Clin Pathol 2006; 59:440-2. [PMID: 16567474 PMCID: PMC1860360 DOI: 10.1136/jcp.2005.026369] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/09/2005] [Indexed: 11/04/2022]
Abstract
BACKGROUND Familial tumoral calcinosis (FTC) is a rare autosomal recessive disease characterised by the development of multiple calcified masses in periarticular soft tissues; GALNT3 gene mutations have recently been described in an African American and in a Druse Arab family with FTC. OBJECTIVE To report the clinical and histological features caused by a new GALNT3 mutation in a white family. RESULTS Homozygosity for the nonsense mutation Lys463X was found in both affected siblings, who displayed a classic phenotype, the male also having testicular microlithiasis. He is the first subject described with testicular microlithiasis in FTC. CONCLUSIONS The high testicular expression of GALNT3 suggests that the gene alteration could act locally by causing deposition of calcium, and the testis may be an underestimated site of calcification in FTC. Autoimmune diseases are present in several members of the family. Although immune disorders have been described in FTC, autoimmunity does not segregate with the GALNT3 mutation in this family.
Collapse
Affiliation(s)
- M F Campagnoli
- Paediatric Department, University of Turin, Turin, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Cussotti S, Ingrosso G, Parola PG, Mellano D, Linari A, Pucci A, Di Rosa G. Tendinous villonodular synovitis: a rare case of recurrence during childhood. Chir Organi Mov 2004; 89:167-70. [PMID: 15645794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Affiliation(s)
- S Cussotti
- Ospedale Infantile Regina Margherita - UOA Ortopedia e Traumatologia Torino
| | | | | | | | | | | | | |
Collapse
|
26
|
Franceschini P, Licata D, Guala A, Ingrosso G, Di Cara G, Franceschini D. Patterson-Lowry rhizomelic dysplasia: Report of two new patients. ACTA ACUST UNITED AC 2004; 127A:86-92. [PMID: 15103724 DOI: 10.1002/ajmg.a.20638] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
We report two new patients with the Patterson-Lowry rhizomelic dysplasia characterized by very short humeri, coxa vara with proximal femoral epiphyseal involvement, short metacarpals, metatarsals and phalanges. The expression of clinical and radiological characteristics is significantly variable, but the unique proximal metaepiphyseal appearance of humeri makes the syndrome easily identifiable. All the reported patients are sporadic. The genetics of the syndrome remain unclear for the moment.
Collapse
Affiliation(s)
- Piergiorgio Franceschini
- Dipartimento di Scienze Pediatriche e dell'Adolescenza, Servizio di Genetica Clinica, Università degli Studi, Torino, Italy
| | - D Licata
- Dipartimento di Scienze Pediatriche e dell'Adolescenza, Servizio di Genetica Clinica, Università degli Studi, Torino, Italy
| | - A Guala
- Ambulatorio di Genetica Clinica, Ospedale "SS. Pietro e Paolo," Borgosesia, Italy
| | - G Ingrosso
- Divisione di Ortopedia e Traumatologia, Ospedale Infantile "Regina Margherita," Torino, Italy
| | - G Di Cara
- Dipartimento di Scienze Pediatriche e dell'Adolescenza, Servizio di Genetica Clinica, Università degli Studi, Torino, Italy
| | - D Franceschini
- I Clinica Ortopedica, Università degli Studi, Torino, Italy
| |
Collapse
|
27
|
Ingrosso G. Palladium(II)- or copper(II)-catalysed solution-phase oxyfunctionalisation of methane and other light alkanes by hydrogen peroxide in trifluoroacetic anhydride. ACTA ACUST UNITED AC 2003. [DOI: 10.1016/s1381-1169(03)00324-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
28
|
Franceschini P, Licata D, Di Cara G, Guala A, Bianchi M, Ingrosso G, Franceschini D. Bladder carcinoma in Costello syndrome: Report on a patient born to consanguineous parents and review. ACTA ACUST UNITED AC 1999. [DOI: 10.1002/(sici)1096-8628(19990910)86:2<174::aid-ajmg17>3.0.co;2-y] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
29
|
Franceschini P, Licata D, Di Cara G, Guala A, Bianchi M, Ingrosso G, Franceschini D. Bladder carcinoma in Costello syndrome: report on a patient born to consanguineous parents and review. Am J Med Genet 1999; 86:174-9. [PMID: 10449656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
We report on a 12-year-old boy with Costello syndrome born to consanguineous (first cousins once removed) parents, supporting the hypothesis of recessive transmission of this syndrome. At age 11 years, the patient developed a bladder carcinoma, a rare pediatric tumor not previously described in Costello syndrome. This suggests that an increased risk of malignancy may be part of this condition.
Collapse
Affiliation(s)
- P Franceschini
- Dipartimento di Scienze Pediatriche e dell'Adolescenza, Servizio di Genetica Clinica, Università di Torino, Italy
| | | | | | | | | | | | | |
Collapse
|
30
|
|
31
|
Abstract
The microsomal epoxide hydrolase (mEH)-catalyzed hydrolysis of cis-4,4'-dimethylstilbene oxide (1a), cis-4,4'-diethylstilbene oxide (1b), cis-4,4'-diisopropylstilbene oxide (1c), and cis-4,4'-dichlorostilbene oxide (1d) have been investigated using rabbit liver microsomal preparations. The kinetic parameters, Km and Vmax, and the absolute stereochemistry of the reactions have been determined and compared with those of cis-stilbene oxide (1e). All epoxides 1a-d are hydrolyzed by mEH with high product enantioselectivity to give (R,R)-(+)-diols with ee > or = 90%. The presence of the substituents on the phenyl rings markedly reduces the rates of mEH catalyzed hydrolysis with respect to cis-stilbene oxide, by increasing Km and reducing Vmax in the cases of 1a, 1b, and 1d, or reducing only the Vmax in the case of 1c. The very low Vmax, together with a persistent ability to fit into the mEH active site, make all these epoxides, and particularly 1c, inhibitors of cis-stilbene oxide hydrolysis. The kinetic and stereochemical results are interpreted on the basis of the proposed topology of the mEH active site.
Collapse
Affiliation(s)
- G Bellucci
- Department of Bioorganic Chemistry, University of Pisa, Italy
| | | | | |
Collapse
|
32
|
|
33
|
Epifani E, Florio S, Ingrosso G, Ronzini L, Sgarra R, Troisi L. Regio- and stereo-chemistry of the coupling reaction of phenylsulphenyl-, phenylsulphinyl- and phenylsulphonyl-pentadienyl metals. Tetrahedron 1991. [DOI: 10.1016/s0040-4020(01)89751-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
34
|
|
35
|
|
36
|
|
37
|
Torre D, Maggiolo F, Sampietro C, Ingrosso G, Issi M, Rossi D. Lymphocyte subpopulations and corticosteroid treatment in patients with pertussis. Am J Dis Child 1986; 140:1094. [PMID: 3766476 DOI: 10.1001/archpedi.1986.02140250020011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
38
|
Ingrosso G, Parenti G, Pelilli E, Pisano G. [Painful torticollis in children]. Chir Organi Mov 1984; 69:341-347. [PMID: 6537271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
39
|
|
40
|
Diversi P, Giusti A, Ingrosso G, Lucherini A. π-Cyclopentadienyl-like derivatives of cobalt: synthesis of indenyl- and fluorenyl-bis(phosphite)-cobalt(I). J Organomet Chem 1981. [DOI: 10.1016/s0022-328x(00)81481-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
|
42
|
De Guidi G, Ingrosso G, Parenti G. [Acute osteoarthritis in newborn infants and in early childhood]. Chir Organi Mov 1981; 67:41-53. [PMID: 6892503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
43
|
Diversi P, Ingrosso G, Lucherini A, Martinelli P, Benetti M, Pucci S. On the formation of (triphenylphosphine)(ethylene)pentamethylcyclopentadienylrhodium(I) in the reaction of diiodo(triphenylphosphine)pentamethylcyclopentadienylrhodium(III) with butane-1,4-bis(magnesium bromide). An example of facile CO cleavage of diethyl ether by an organomagnesium compound. J Organomet Chem 1979. [DOI: 10.1016/s0022-328x(00)94327-4] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
44
|
Borrini A, Ingrosso G. The reaction of allene with compounds of the type (β-diketonato)Rh(CO)2: Preparation and properties of dinuclear rhodium(I)-allene complexes and of η3-allylic derivatives of rhodium(III). J Organomet Chem 1977. [DOI: 10.1016/s0022-328x(00)91734-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
45
|
Diversi P, Ingrosso G, Immirzi A, Porzio W, Zocchi M. The reaction of allene with β-diketonatoiridium(I) complexes: synthesis, properties and crystal structures of bis(η3-allyllic) complexes of iridium(III) and of iridocyclopentane derivatives. J Organomet Chem 1977. [DOI: 10.1016/s0022-328x(00)89444-9] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
46
|
Brisse F, Beauchamp AL, Richer JC, Bellucci G, Ingrosso G. Structure cristalline et moléculaire du p-nitrobenzoate du bromo-2 tert-butyl-6 cyclohexanol trans– trans, C 17H 22NO 4Br. Acta Crystallogr Sect B 1976. [DOI: 10.1107/s0567740876007255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
47
|
Diversi P, Ingrosso G, Immirzi A, Zocchi M. The reaction of allene with β-diketonatoiridium(I) compelexes: Formation and crystal structure of a new iridocyclopentane derivative. J Organomet Chem 1976. [DOI: 10.1016/s0022-328x(00)91599-7] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
48
|
Diversi P, Ingrosso G, Immirzi A, Zocchi M. The reaction of allene with β-diketonatoiridium(I) complexes: formation and crystal structure of a new bis-β-allylic derivative of iridium(III). J Organomet Chem 1975. [DOI: 10.1016/s0022-328x(00)89403-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
49
|
Ingrosso G, Porri L, Pantini G, Racanelli P. The reaction of allene with β-diketonatorhodium(I) complexes: Formation of bis(π-allylic) complexes of rhodium(III) and of rhodacyclopentane derivatives. J Organomet Chem 1975. [DOI: 10.1016/s0022-328x(00)88776-8] [Citation(s) in RCA: 37] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Ingrosso G, Immirzi A, Porri L. The reaction of allene with β-diketonatorhodium(I) complexes: formation and structure of new rhodacyclopentane derivatives. J Organomet Chem 1973. [DOI: 10.1016/s0022-328x(00)85426-1] [Citation(s) in RCA: 36] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|